CN1062769C - Medicine for anti-anoxia and treating chronic hepatitis - Google Patents
Medicine for anti-anoxia and treating chronic hepatitis Download PDFInfo
- Publication number
- CN1062769C CN1062769C CN98126419A CN98126419A CN1062769C CN 1062769 C CN1062769 C CN 1062769C CN 98126419 A CN98126419 A CN 98126419A CN 98126419 A CN98126419 A CN 98126419A CN 1062769 C CN1062769 C CN 1062769C
- Authority
- CN
- China
- Prior art keywords
- chronic hepatitis
- medicine
- present
- tangut
- plateaus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for resisting anoxia and treating chronic hepatitis, which is characterized in that the present invention is prepared from active raw materials of the following weight percentage according to a dosage per tablet: 0.1% to 99% of Tangut cream clematis root or herb, 0.1% to 99% of rubus phoenicolasius Maxim., 0.1% to 99% of Tangut sorrel rhubarb, 0.1% to 80% of cynomorium songaricum, 0.1% to 99% of astragalus root and 0.1% to 99% of licorice root. The medicine can adjust and relieve the unbalanced metaboly of oxygen free radicals in the bodies of people in plateaus and patients with chronic hepatitis in plateaus, enhance the erythrocyte immune function of an organism, improve the partial pressure of blood oxygen in the organism, and lower glutamic pyruvic transaminase and glutamic-oxalacetic transaminase in the bodies of the patients with chronic hepatitis to transfer hepatitis virus to be negative. The present invention has favorable effect of protecting a liver function, and has the advantages of high therapeutic effect and no toxic or side effect.
Description
The invention belongs to a kind of Tibetan medicine, the medicine of particularly a kind of anti-hypoxia, treatment chronic hepatitis.
Studies show that high aborigines show as senilism, senilism and easily suffer from some altitude sickness because of the influence of its hypoxia, hypobaric.In recent years research discloses, there is tangible radical metabolism disorder in the human body of plateau, this radical metabolism is unbalance to be to cause high protoplast's senilism and some altitude sickness that the one of the main reasons that develops takes place, and raises with height above sea level, and plateau crowd's body radical metabolism is unbalance more obvious.There are some researches show that also under the environment of low oxygen plateau, chronic hepatitis patient body radical metabolism is unbalance, it is the one of the main reasons that causes the chronic hepatitis patient state of an illness to increase the weight of that hematid immunity function goes down.
Chronic hepatitis also is commonly encountered diseases, the frequently-occurring disease in China's internal disease, and its serious consequence can cause liver cirrhosis, hepatocarcinoma etc., and treatment at present is many based on comprehensive therapy.Because it is closely related that chronic hepatitis virus continues to duplicate with the liver damage, therefore suppress the emphasis that virus replication becomes the treatment chronic hepatitis.
Tibetan medicine and pharmacology has a long history and good common people basis.Tibetan medicine is because of its growing environment uniqueness, the efficacy of a drug are strong, good drug efficacy and pollution-free, belongs to the pure natural plant medical material and is subjected to the favor of Tibetan people deeply.But for a certain reason, the development and use and the pharmacological research thereof of relevant Tibetan medicine also are in hysteretic state.Therefore, how from Tibetan medicine, to develop anti-hypoxia, the treatment chronic hepatitis medicine be the target that the medical worker extremely yearns for.
The objective of the invention is to utilize Qinghai-Tibet pure natural Tibetan medicine, Chinese crude drug that the medicine of a kind of anti-hypoxia, treatment chronic hepatitis is provided, it has adjusting and improvement effect for high aborigines and the intravital radical metabolism disorder of plateau chronic hepatitis patient, energy enhancing body hematid immunity function, reduce chronic hepatitis patient glutamate pyruvate transaminase and glutamic oxaloacetic transaminase, GOT, have the effect that chronic hepatitis virus is turned out cloudy simultaneously.This medicine good effect, have no side effect.
The present invention is achieved in that Clematistangutica (Maxim.) Korsh., Radix seu Folium Rubi phoenicolasii, Rheum tanguticum, Herba Cynomorii, the Radix Astragali, the Radix Glycyrrhizae with pure natural Qinghai-Tibet Platean local products is that raw material develops through science processing compatibility.It is characterized in that it is to make with the activated feedstock of the percentage by weight of following every consumption:
Clematistangutica (Maxim.) Korsh. 8%-25% Radix seu Folium Rubi phoenicolasii 2%-30%
Rheum tanguticum 5%-50% Herba Cynomorii 10%-40%
Radix Astragali 5%-15% Radix Glycyrrhizae 5%-15%.
Medicine provided by the invention can make the malonaldehyde (MDA) of body reflection oxygen-derived free radicals content obviously reduce, the ability of removing oxygen-derived free radicals strengthens, be that superoxide dismutase (SOD) raises, hematid immunity function strengthens, show that this medicine has adjusting and improvement effect to radical metabolism disorder in the human body, energy enhancing human body immunity function, improve the body blood oxygen pressure, have the effect of anti-hypoxia and interior glutamate pyruvate transaminase of reduction plateau chronic hepatitis patient body and glutamic oxaloacetic transaminase, GOT, and chronic hepatitis virus is turned out cloudy.The effective in cure height of this medical instrument has no side effect.
Manufacturing process of the present invention is conventional technology, promptly earlier with the infusion and concentrate and make fluid extract respectively in proportion of various medicines, extract the dry (being active ingredient) in the fluid extract, mix and add adjuvant then and can be made into various dosage forms such as oral liquid, capsule, tablet, powder.
It below is several full implementation example of the present invention
Embodiment 1:
Clematistangutica (Maxim.) Korsh. 20% Radix seu Folium Rubi phoenicolasii 20%
Rheum tanguticum 20% Herba Cynomorii 15%
The Radix Astragali 10% Radix Glycyrrhizae 15%
In the mixture of active ingredient, add syrup, make nourushing syrup with medicine-feeding.
Embodiment 2:
Clematistangutica (Maxim.) Korsh. 8% Radix seu Folium Rubi phoenicolasii 20%
Rheum tanguticum 50% Herba Cynomorii 20%
The Radix Astragali 10% Radix Glycyrrhizae 10%
In the mixture of active ingredient, make tablet with soluble starch with medicine-feeding.
Embodiment 3:
Clematistangutica (Maxim.) Korsh. 15% Radix seu Folium Rubi phoenicolasii 30%
Rheum tanguticum 5% Herba Cynomorii 40%
The Radix Astragali 5% Radix Glycyrrhizae 5%
In the mixture of active ingredient, make capsule with soluble starch with medicine-feeding.
Embodiment 4:
Clematistangutica (Maxim.) Korsh. 25% Radix seu Folium Rubi phoenicolasii 25%
Rheum tanguticum 10% Herba Cynomorii 10%
The Radix Astragali 15% Radix Glycyrrhizae 15%
In the mixture of active ingredient, make powder with soluble starch with medicine-feeding.
Claims (1)
1, the medicine of a kind of anti-hypoxia, treatment chronic hepatitis, it is characterized in that it is to make with the activated feedstock of the percentage by weight of following every consumption: Clematistangutica (Maxim.) Korsh. 8%-25%, Radix seu Folium Rubi phoenicolasii 2%-30%, Rheum tanguticum 5%-50%, Herba Cynomorii 10%-40%, Radix Astragali 5%-15%, Radix Glycyrrhizae 5%-15%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98126419A CN1062769C (en) | 1998-12-25 | 1998-12-25 | Medicine for anti-anoxia and treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98126419A CN1062769C (en) | 1998-12-25 | 1998-12-25 | Medicine for anti-anoxia and treating chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1228984A CN1228984A (en) | 1999-09-22 |
| CN1062769C true CN1062769C (en) | 2001-03-07 |
Family
ID=5229659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98126419A Expired - Fee Related CN1062769C (en) | 1998-12-25 | 1998-12-25 | Medicine for anti-anoxia and treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1062769C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1308014C (en) * | 2004-06-28 | 2007-04-04 | 张克 | Medicine for treating hepatitis B hepatitis C, hepatitis cirrhosis |
| CN101912456B (en) * | 2010-07-28 | 2012-09-19 | 福建中医药大学 | Novel application of rubus alceaefolius poir total alkaloid |
-
1998
- 1998-12-25 CN CN98126419A patent/CN1062769C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 天然产物研究与开发7(2) 1995.1.1 宋电宏 铁线莲属植物的化学成分及药理作用研究概况 * |
| 江西中医药21(5)22(1)22(4) 1990.1.1 周嘉善 肝类的草药治疗(一)-(四) * |
| 江西中医药21(5)22(1)22(4) 1990.1.1 周嘉善 肝类的草药治疗(一)-(四);沈阳药学院学报11(1) 1994.1.1 刘明生 悬钩子属植物化学成分的研究概况;天然产物研究与开发7(2) 1995.1.1 宋电宏 铁线莲属植物的化学成分及药理作用研究概况 * |
| 沈阳药学院学报11(1) 1994.1.1 刘明生 悬钩子属植物化学成分的研究概况 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1228984A (en) | 1999-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1824205A (en) | Medicine for treating chronic prostatitis and its preparation method | |
| CN1069542C (en) | Medicine for treating chronic hepatism and its preparing process | |
| CN1062769C (en) | Medicine for anti-anoxia and treating chronic hepatitis | |
| CN1056755C (en) | Medicine of curing hepatitis | |
| CN1720965A (en) | Chinese medicinal composition for treating acute icterohepatitis | |
| CN1059559C (en) | Oral medicine and external-use medicine for curing osteonosus and processing method thereof | |
| CN1903276A (en) | Medicinal composition for treating hepatitis B | |
| CN1087617C (en) | Hepatitis curing capsule | |
| CN1404868A (en) | Chinese medicinal preparation for treating pyretic stranguria | |
| CN1074285C (en) | Chinese medicine for curing appendicitis | |
| CN1176690C (en) | Medicine for treating chronic nephritis | |
| CN1255149C (en) | Combination of medication | |
| CN1086300C (en) | Prescription for treating hepatism | |
| CN1203804A (en) | Ganbingkang medicine for curing liver disease | |
| CN1695639A (en) | Chinese traditional medicine for treating dysmenorrhea and irregular menses, and preparation method | |
| CN1193787C (en) | Immunoregulator for preventing and treating AIDS | |
| CN1097139A (en) | The compounded solid oral medicine of treatment upper respiratory tract infection | |
| CN1879786A (en) | A Chinese herbal medicament for treating hepatitis B | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
| CN100350943C (en) | Medicinal composition for treating hepatitis B and preparation method thereof | |
| CN1149492A (en) | Technology for producing strengthening waist and invigorating kidney oral liquor | |
| CN1054043C (en) | Pharmaceutical composition for treating typhoid fever | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| CN1200290A (en) | Medicine recipe for treating liver disease | |
| CN1058404C (en) | Hepatitis B treating medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010307 Termination date: 20151225 |
|
| EXPY | Termination of patent right or utility model |